Acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
Mutations in human epidermal growth factor receptor 2 (HER2) were found to confer resistance to hormone therapy in some estrogen receptor (ER)-positive metastatic breast cancer cases, and resistance could be reversed by dual ...
Mar 19, 2018
0
8